| 000 | 01622 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250513051541.0 | ||
| 264 | 0 | _c19941018 | |
| 008 | 199410s 0 0 eng d | ||
| 022 | _a0959-8138 | ||
| 024 | 7 |
_a10.1136/bmj.309.6950.309 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPhillips, A N | |
| 245 | 0 | 0 |
_aUse of CD4 lymphocyte count to predict long-term survival free of AIDS after HIV infection. _h[electronic resource] |
| 260 |
_bBMJ (Clinical research ed.) _cJul 1994 |
||
| 300 |
_a309-13 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAcquired Immunodeficiency Syndrome _xblood |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aCD4-Positive T-Lymphocytes _ximmunology |
| 650 | 0 | 4 |
_aCandidiasis _xprevention & control |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 |
_aHIV Seropositivity _xblood |
| 650 | 0 | 4 |
_aHIV-1 _ximmunology |
| 650 | 0 | 4 |
_aHemophilia A _xcomplications |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLeukocyte Count |
| 650 | 0 | 4 | _aLogistic Models |
| 650 | 0 | 4 |
_aLondon _xepidemiology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPneumonia, Pneumocystis _xprevention & control |
| 650 | 0 | 4 | _aSensitivity and Specificity |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aZidovudine _xtherapeutic use |
| 700 | 1 | _aSabin, C A | |
| 700 | 1 | _aElford, J | |
| 700 | 1 | _aBofill, M | |
| 700 | 1 | _aJanossy, G | |
| 700 | 1 | _aLee, C A | |
| 773 | 0 |
_tBMJ (Clinical research ed.) _gvol. 309 _gno. 6950 _gp. 309-13 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1136/bmj.309.6950.309 _zAvailable from publisher's website |
| 999 |
_c7915556 _d7915556 |
||